Company Filing History:
Years Active: 2012
Title: The Innovations of Nicholas Stergis
Introduction
Nicholas Stergis is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. His innovative approach has led to the development of a unique method that enhances patient care.
Latest Patents
Stergis holds a patent for a method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids. This patent describes a method of administration of an oral pharmaceutical product to patients suffering from such disorders. The method involves orally administering at least two different dosage forms of a therapeutically effective amount of a topically active corticosteroid, such as beclomethasone dipropionate (BDP). This innovative approach aims to improve the efficacy of treatment for patients.
Career Highlights
Nicholas Stergis is associated with Soligenix, Inc., a company dedicated to developing innovative therapeutics. His work at Soligenix has been instrumental in advancing treatment options for patients with gastrointestinal disorders. With 1 patent to his name, Stergis continues to push the boundaries of pharmaceutical innovation.
Collaborations
Throughout his career, Stergis has collaborated with notable colleagues, including George McDonald and George B McDonald. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Nicholas Stergis exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in treating inflammatory disorders, highlight the importance of research and development in improving patient outcomes.